MAAT INDEX

CLAIM #11982 · Bristol-Myers Squibb Company (BMY) · 2024Q2 earnings call · Jul 26, 2024 · due Dec 31, 2024

Yeah, thanks, Terence. And look, we remain committed to our greater than 37% operating margin.

David Elkins · CFO

PENDING
graded after results covering Dec 31, 2024 are reported

In context

s that are happening in the landscape. Chris Boerner: Yeah. And just to close off on that, what I would say when we look at Part-D redesign across the entire portfolio, we actually think that it offsets and would be largely meaningful. Tim Power: Great. Thanks, Chris. Can we go to the next question, please? Operator: Absolutely. Our next question today comes from Terence Flynn at Morgan Stanley. Please go ahead. Terence Flynn: Great. Thanks so much for taking the question. David, I was just wondering if you can provide any early commentary on how we should think about 2025 operating margins, maybe just walking us through some of the puts and takes. And then separately, I was wondering if you guys can disclose the WINREVAIR royalty from Merck? Thank you. Chris Boerner: David? David Elkins: Yeah, thanks, Terence. And look, we remain committed to our greater than 37% operating margin. And as you saw, we saw strength in our gross margins with our mix of our business. And we feel really good about the operational efficiency programs that we're executing against now, which gives us a lot of flexibility in maintaining those operating margins above 37%. Thanks, Terence. Terence Flynn: And about WINREVAIR, David? David Elkins: And WINREVAIR that, so we recognized 22% of global sales of WINREVAIR that comes through our other growth revenue that comes through there and you'll hear about those sales from Merck when they come through. Terence Flynn: Great. David Elkins: But obviously an important growth driver for us is that 22% royalty rate. Tim Power: Great. Thanks very much, David. Can we go to the next one, please, Rocco? Operator: Yes, sir. Our next question today comes fro

Verify independently

SEC filings for BMY · Claim quote is verbatim from the 2024Q2 earnings call.